Avalon GloboCare

What Avalon GloboCare does

Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial-stage micro-cap company headquartered in Freehold, New Jersey, operating two business segments: Consumer Health and Agentic AI. Founded in 2015 and incorporated in Delaware, the company employs 1 to 10 staff and carries a market capitalization ranging from approximately $2.53 million to $5.7 million across late 2025 and early 2026. The company's strategic positioning shifted materially with the December 2025 acquisition of RPM Interactive, which was merged into a newly formed subsidiary, Avalon Quantum AI LLC, reorienting the business around AI-enabled digital content and consumer health.

The product portfolio spans three pillars. The Consumer Health segment is anchored by the KetoAir handheld breathalyzer, an FDA-registered Class I medical device (registration number 3026284320) using nanosensor technology to non-invasively measure ketosis levels for ketogenic diet management, athletic performance, and therapeutic ketogenic programs; the device is sold via B2B and B2C channels in North America with planned Q2 2026 launch. The Agentic AI segment centers on Catch-Up, a SaaS platform acquired via RPM Interactive that automates the creation and distribution of short-form video, audio, and digital media content for social media influencers, podcasters, and digital content creators, currently undergoing Phase 2 development with Caylent and AWS to convert it into a fully autonomous agentic AI system. The company also maintains joint intellectual property with the Massachusetts Institute of Technology for the QTY protein design platform supporting precision diagnostics development.

Avalon GloboCare generates revenue through SaaS platform licensing for Catch-Up, hardware sales of KetoAir devices, and AI-powered marketing services leveraging the Catch-Up platform for consumer health products. The company reported 119% revenue growth over the trailing twelve months but continues to operate at a loss with negative EBITDA of $6.9 million and negative stockholders' equity of $3.9 million, triggering a Nasdaq non-compliance notice. The balance sheet has been reinforced through the $19.5 million RPM Interactive all-stock acquisition and a February 2026 private placement of approximately $3.25 million led by H.C. Wainwright & Co. and Roth Capital Partners, with up to $6.5 million of additional proceeds contingent on warrant exercises. The company has also announced a proposed merger with YOOV Group Holding Limited.

Name

Avalon GloboCare

Legal name

Avalon GloboCare Corp.

Website

https://avalon-globocare.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial-stage micro-cap operating in Consumer Health (FDA-registered KetoAir breathalyzer) and Agentic AI (Catch-Up video content platform), serving ketogenic diet consumers, wellness programs, and digital content creators.

Ownership category

akta.pro rank

Product category

AI Video Generation Software

NAICS

Software Publishers (5132), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

akta.pro secondary industries

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML Engineering & Model Development Services (BPAEAHAF)

Keywords

• Agentic AI video platform
• Consumer health devices
• Medical breathalyzer devices
• AI content automation
• Metabolic health monitoring

Headquarters

HQ city

Freehold

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. SaaS Platform Licensing: Catch-Up agentic AI video platform licensed to content creators, media companies, and brands on a subscription or usage basis for automated video content generation and distribution.
2. KetoAir Device Sales: Sale of KetoAir handheld breathalyzer devices for ketogenic health management targeting B2B and B2C markets in North America.
3. AI-Powered Marketing Services: Leveraging Catch-Up AI platform to support marketing efforts for consumer health products like KetoAir, enabling digital engagement and content-driven monetization.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Avalon GloboCare commercially delivers the Catch-Up agentic AI SaaS video-generation platform (via subsidiary Avalon Quantum AI LLC) for automated short-form video and digital content creation, and the KetoAir FDA-registered Class I medical breathalyzer device that non-invasively measures ketosis using nanosensor technology for ketogenic health management. The company also holds joint IP with MIT for the QTY protein design platform supporting precision diagnostics research.

Product overview

Avalon GloboCare operates as a commercial-stage company with two core business segments: Consumer Health and Agentic AI Technology. The Consumer Health segment centers on the KetoAir breathalyzer device (FDA-registered Class I medical device) that measures ketosis levels using proprietary nanosensor technology. The Agentic AI segment is anchored by the Catch-Up platform, an AI-powered SaaS product acquired through the December 2025 purchase of RPM Interactive. The Catch-Up platform transforms from a manually-configured AI video production system into a fully autonomous, agentic AI-driven video platform enabling social media influencers and digital content creators to generate personalized video content at scale. The company also holds joint intellectual property with MIT for the QTY protein design platform. The AI and consumer health divisions are designed to complement each other, with the Catch-Up platform being used to support marketing for KetoAir and other consumer health products.

Differentiator

Problem solved

Functional benefit

Brands

• KetoAir: FDA-registered Class I medical device breathalyzer that measures ketosis levels using nanosensor technology, sold in North America for ketogenic health management.
• Catch-Up
• Avalon Quantum AI

Products and services

• Catch-Up Agentic AI Video Platform The Catch-Up platform is an agentic AI-powered SaaS solution that automates the creation and distribution of short-form video and digital media content at scale. It enables social media influencers, podcasters, and digital content creators to generate personalized video content across multiple platforms with minimal technical expertise, and serves brands and media companies as enterprise customers seeking AI-powered video content generation and digital marketing automation.
• KetoAir Breathalyzer Device KetoAir is a non-invasive handheld breathalyzer device that measures ketosis levels using proprietary nanosensor technology. It is registered with the U.S. Food and Drug Administration as a Class I medical device (registration number 3026284320), maintained under Qi Diagnostics Limited, and is sold in North America to health-conscious consumers following ketogenic diets for weight management, athletic performance, and therapeutic programs, as well as to organizations and government wellness programs (e.g., the Nevada POOL/PACT first responder program).

Quantifiable outcome

• 66% average participant engagement rate in Nevada first responder wellness program
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Caylent, Inc.coreImplementation/ SI/ Consulting Partner · 31 March 2026Caylent, an AWS Premier Tier Consulting Partner, was appointed to lead Phase 2 development of the Catch-Up platform. The collaboration aims to transform the platform from a manually configured AI video production system into a fully autonomous, agentic AI-driven video platform. Caylent has been recognized as AWS Migration Consulting Partner of the Year, GenAI Industry Solution Partner of the Year, and Application Modernization Partner of the Year.
• Amazon Web Services (AWS)coreTechnology or Integration · 31 March 2026AWS collaboration supporting Phase 2 development of the Catch-Up agentic AI video platform. AWS provides the cloud infrastructure foundation for the platform's transition into a fully autonomous system enabling non-technical content creators to generate personalized video content across social media platforms.
• Advanced Micro Devices (AMD)coreTechnology or Integration · 26 February 2026Avalon Quantum AI LLC was accepted into the AMD AI Developer Program, gaining access to AMD Developer Cloud credits, advanced tools, training, and high-performance compute resources powered by AMD Instinct accelerators and EPYC processors. This partnership is intended to accelerate automated commentary video generation, enterprise documentation tools, and AI-powered workflow automation.
• Saga Health and SpecialtyHealth, Inc.minorStrategic or Co-development Partner · 1 August 2025Collaboration for the Nevada POOL/PACT Holistic Health Reset program, a four-month wellness initiative launched August 2025 designed to support 50 first responders using Avalon's KetoAir breath-based metabolic monitoring technology. Mid-program data demonstrated improvements in metabolic health metrics among participants.
• Qi Diagnostics LimitedminorStrategic or Co-development Partner · 25 October 2024Memorandum of understanding for proposed co-development of a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. The MOU provided Avalon with a 120-day exclusivity period to negotiate a definitive agreement for initial prototype-enabling stage involving critical research, data collection, software development, and prototype design.
• YOOV Group Holding LimitedminorStrategic or Co-development PartnerProposed merger with YOOV Group Holding Limited, for which relevant materials have been filed with the SEC. This represents a potential strategic transaction for the company.
• Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerJoint intellectual property arrangement for QTY protein design platform, representing a strategic research partnership for precision diagnostics development.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Descript: Descript provides AI-powered video and audio editing tools aimed at podcasters and content creators. Its automation of editing workflows parallels Catch-Up's agentic approach to short-form video production.
• HeyGen: HeyGen offers an AI video generation platform with avatars and multilingual video creation capabilities for marketing, sales, and content teams. It competes in the same AI-driven video automation space as Catch-Up.
• Pika Labs: Pika Labs develops generative AI video tools that enable creators to produce and edit short-form video content from text prompts. Its focus on accessible AI video generation aligns closely with Catch-Up's target user base.
• Synthesia: Synthesia provides AI-generated video with avatars for enterprise training, marketing, and content creation. It is a direct competitor in automated AI video production targeting business and creator use cases.
• InVideo: InVideo offers an AI-driven video creation platform with templates and automation targeted at marketers and creators. It overlaps with Catch-Up on scalable AI video production for digital content.
• Runway: Runway is a leading AI video generation platform used by content creators, filmmakers, and brands to produce video from text and image prompts. It directly competes with Catch-Up in the agentic AI short-form video creation category.

Broad incumbents

• Canva (Magic Studio): Canva's Magic Studio integrates AI video and design tools within a broad creative platform used by creators and businesses. It competes with Catch-Up on AI-assisted content creation but offers a much wider portfolio of design and collaboration tools.
• Bio-Techne: Bio-Techne provides reagents, assays, and proteomic research tools widely used in life science research. It is broadly comparable to Avalon's biotech diagnostics ambitions (QTY protein design platform) as a larger incumbent in protein-related life sciences.

Emerging players

• Lumen Health: Lumen is a handheld breath-based metabolic tracker that measures fat metabolism via breath acetone. It is a direct adjacent peer to KetoAir's non-invasive breath-based ketosis monitoring approach for ketogenic diet and metabolic wellness users.
• Levels Health: Levels Health offers a continuous glucose monitor paired with software for metabolic health tracking. It is comparable to Avalon's KetoAir as a consumer-facing metabolic monitoring product targeting wellness-oriented users.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/avalonglobocare

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avalon GloboCare